Leukotriene B4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo.

[1]  S. Peters,et al.  Generation of leukotriene B4 by human lung fragments and purified human lung mast cells. , 1988, The American review of respiratory disease.

[2]  W. Henderson,et al.  Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage. , 1987, The Journal of clinical investigation.

[3]  S. Peters,et al.  Purified human basophils do not generate LTB4. , 1987, Biochemical pharmacology.

[4]  R. Naclerio,et al.  Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. , 1987, The Journal of clinical investigation.

[5]  A. Sala,et al.  Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis. , 1987, The American review of respiratory disease.

[6]  P. O'Byrne,et al.  Leukotriene B4 induces airway hyperresponsiveness in dogs. , 1985, Journal of applied physiology.

[7]  A. Togias,et al.  Inflammatory mediators in late antigen-induced rhinitis. , 1985, The New England journal of medicine.

[8]  A. Wardlaw,et al.  Allergen‐Induced Release of Sulphidopeptide Leukotrienes (SRS‐A) and LTB4 in Allergic Rhinitis , 1985, Allergy.

[9]  R. Schleimer.  The mechanisms of antiinflammatory steroid action in allergic diseases. , 1985, Annual review of pharmacology and toxicology.

[10]  S. Shak,et al.  Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. , 1984, The Journal of biological chemistry.

[11]  R. Naclerio,et al.  Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. , 1984, The New England journal of medicine.

[12]  K. Austen,et al.  The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology. , 1984, The Journal of clinical investigation.

[13]  S. Peters,et al.  Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. , 1983, The Journal of clinical investigation.

[14]  A. Capron,et al.  Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients. , 1983, The Journal of clinical investigation.

[15]  M. A. Bray.  The pharmacology and pathophysiology of leukotriene B4. , 1983, British medical bulletin.

[16]  A. B. Kay,et al.  Neutrophil chemotactic activity in antigen-induced late asthmatic reactions. , 1982, The New England journal of medicine.

[17]  R. Crystal,et al.  Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization. , 1980, The Journal of clinical investigation.

[18]  M. A. Bray,et al.  Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes , 1980, Nature.

[19]  Z. Pelikan.  Late and delayed responses of the nasal mucosa to allergen challenge. , 1978, Annals of allergy.